Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial
- PMID: 29998338
- PMCID: PMC6583520
- DOI: 10.1001/jama.2018.8907
Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial
Abstract
Importance: Musculoskeletal symptoms are the most common adverse effects of aromatase inhibitors and often result in therapy discontinuation. Small studies suggest that acupuncture may decrease aromatase inhibitor-related joint symptoms.
Objective: To determine the effect of acupuncture in reducing aromatase inhibitor-related joint pain.
Design, setting, and patients: Randomized clinical trial conducted at 11 academic centers and clinical sites in the United States from March 2012 to February 2017 (final date of follow-up, September 5, 2017). Eligible patients were postmenopausal women with early-stage breast cancer who were taking an aromatase inhibitor and scored at least 3 on the Brief Pain Inventory Worst Pain (BPI-WP) item (score range, 0-10; higher scores indicate greater pain).
Interventions: Patients were randomized 2:1:1 to the true acupuncture (n = 110), sham acupuncture (n = 59), or waitlist control (n = 57) group. True acupuncture and sham acupuncture protocols consisted of 12 acupuncture sessions over 6 weeks (2 sessions per week), followed by 1 session per week for 6 weeks. The waitlist control group did not receive any intervention. All participants were offered 10 acupuncture sessions to be used between weeks 24 and 52.
Main outcomes and measures: The primary end point was the 6-week BPI-WP score. Mean 6-week BPI-WP scores were compared by study group using linear regression, adjusted for baseline pain and stratification factors (clinically meaningful difference specified as 2 points).
Results: Among 226 randomized patients (mean [SD] age, 60.7 [8.6] years; 88% white; mean [SD] baseline BPI-WP score, 6.6 [1.5]), 206 (91.1%) completed the trial. From baseline to 6 weeks, the mean observed BPI-WP score decreased by 2.05 points (reduced pain) in the true acupuncture group, by 1.07 points in the sham acupuncture group, and by 0.99 points in the waitlist control group. The adjusted difference for true acupuncture vs sham acupuncture was 0.92 points (95% CI, 0.20-1.65; P = .01) and for true acupuncture vs waitlist control was 0.96 points (95% CI, 0.24-1.67; P = .01). Patients in the true acupuncture group experienced more grade 1 bruising compared with patients in the sham acupuncture group (47% vs 25%; P = .01).
Conclusions and relevance: Among postmenopausal women with early-stage breast cancer and aromatase inhibitor-related arthralgias, true acupuncture compared with sham acupuncture or with waitlist control resulted in a statistically significant reduction in joint pain at 6 weeks, although the observed improvement was of uncertain clinical importance.
Trial registration: ClinicalTrials.gov Identifier: NCT01535066.
Conflict of interest statement
Figures


Comment in
-
Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients.JAMA. 2018 Dec 4;320(21):2269-2270. doi: 10.1001/jama.2018.16736. JAMA. 2018. PMID: 30512092 No abstract available.
-
Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients.JAMA. 2018 Dec 4;320(21):2270. doi: 10.1001/jama.2018.16740. JAMA. 2018. PMID: 30512093 No abstract available.
Similar articles
-
Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor-Related Joint Pain: A Randomized Clinical Trial.JAMA Netw Open. 2022 Nov 1;5(11):e2241720. doi: 10.1001/jamanetworkopen.2022.41720. JAMA Netw Open. 2022. PMID: 36367721 Free PMC article. Clinical Trial.
-
Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.J Clin Oncol. 2010 Mar 1;28(7):1154-60. doi: 10.1200/JCO.2009.23.4708. Epub 2010 Jan 25. J Clin Oncol. 2010. PMID: 20100963 Clinical Trial.
-
A randomised trial of electro-acupuncture for arthralgia related to aromatase inhibitor use.Eur J Cancer. 2014 Jan;50(2):267-76. doi: 10.1016/j.ejca.2013.09.022. Epub 2013 Oct 24. Eur J Cancer. 2014. PMID: 24210070 Free PMC article. Clinical Trial.
-
Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer: A meta-analysis of randomized controlled trials.Breast. 2017 Jun;33:132-138. doi: 10.1016/j.breast.2017.03.015. Epub 2017 Apr 4. Breast. 2017. PMID: 28384564 Review.
-
Acupuncture for joint symptoms related to aromatase inhibitor therapy in postmenopausal women with early-stage breast cancer: a narrative review.Acupunct Med. 2015 Jun;33(3):188-95. doi: 10.1136/acupmed-2014-010735. Epub 2015 Mar 2. Acupunct Med. 2015. PMID: 25733539 Review.
Cited by
-
Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor-Related Joint Pain: A Randomized Clinical Trial.JAMA Netw Open. 2022 Nov 1;5(11):e2241720. doi: 10.1001/jamanetworkopen.2022.41720. JAMA Netw Open. 2022. PMID: 36367721 Free PMC article. Clinical Trial.
-
Adverse Events and Perception of Benefit From Duloxetine for Treating Aromatase Inhibitor-Associated Arthralgias.JNCI Cancer Spectr. 2021 Feb 8;5(2):pkab018. doi: 10.1093/jncics/pkab018. eCollection 2021 Apr. JNCI Cancer Spectr. 2021. PMID: 33842832 Free PMC article. Clinical Trial.
-
Acupuncture for chronic uncomplicated musculoskeletal pain associated with the spine: A systematic review protocol.Medicine (Baltimore). 2019 Jan;98(2):e14055. doi: 10.1097/MD.0000000000014055. Medicine (Baltimore). 2019. PMID: 30633205 Free PMC article.
-
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.Breast Cancer Res Treat. 2023 Dec;202(3):473-483. doi: 10.1007/s10549-023-07097-6. Epub 2023 Sep 9. Breast Cancer Res Treat. 2023. PMID: 37688665 Free PMC article.
-
Acupuncture and Vitamin D for the Management of Aromatase Inhibitor-Induced Arthralgia.Curr Oncol Rep. 2019 Apr 17;21(6):51. doi: 10.1007/s11912-019-0795-1. Curr Oncol Rep. 2019. PMID: 30997616 Review.
References
-
- Burstein HJ, Lacchetti C, Anderson H, et al. . Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression. J Clin Oncol. 2016;34(14):1689-1701. - PubMed
-
- Crew KD, Greenlee H, Capodice J, et al. . Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol. 2007;25(25):3877-3883. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical